How can rates of prostate-specific antigen screening be reduced in men aged 80 and older?

J Am Geriatr Soc. 2010 Apr;58(4):757-9. doi: 10.1111/j.1532-5415.2010.02779.x.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Aged, 80 and over*
  • Health Care Rationing
  • Health Services Misuse / statistics & numerical data
  • Humans
  • Male
  • Mass Screening / statistics & numerical data*
  • Patient Acceptance of Health Care
  • Patient Selection*
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / mortality
  • United States / epidemiology

Substances

  • Prostate-Specific Antigen